Search Results - "Lampl, C"

The cost of headache disorders in Europe: the Eurolight project by Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Andrée, C.

“…Background and purpose:  Headache disorders are very common, but their monetary costs in Europe are unknown. We performed the first comprehensive estimation of…”
Get full text

Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis by Lampl, C, Likar, R

“…Metamizole (dipyrone) is a nonsteroidal compound with strong analgesic as well as antipyretic and spasmolytic properties. Based on a small number of cases of…”
Get full text

From transformation to chronification of migraine: pathophysiological and clinical aspects by Torres-Ferrús, M., Ursitti, F., Alpuente, A., Brunello, F., Chiappino, D., de Vries, T., Di Marco, S., Ferlisi, S., Guerritore, L., Gonzalez-Garcia, N., Gonzalez-Martinez, A., Khutorov, D., Kritsilis, M., Kyrou, A., Makeeva, T., Minguez-Olaondo, A., Pilati, L., Serrien, A., Tsurkalenko, O., Van den Abbeele, D., van Hoogstraten, W. S., Lampl, C.

“…Chronic migraine is a neurological disorder characterized by 15 or more headache days per month of which at least 8 days show typical migraine features. The…”
Get full text

European headache federation consensus on technical investigation for primary headache disorders by Mitsikostas, D. D., Ashina, M., Craven, A., Diener, H. C., Goadsby, P. J., Ferrari, M. D., Lampl, C., Paemeleire, K., Pascual, J., Siva, A., Olesen, J., Osipova, V., Martelletti, P.

“…The diagnosis of primary headache disorders is clinical and based on the diagnostic criteria of the International Headache Society (ICHD-3-beta). However…”
Get full text

Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura by Lampl, C, Katsarava, Z, Diener, H-C, Limmroth, V

“…This study examined the efficacy of lamotrigine in the prevention of migraine aura. Fifty nine patients suffering from migraine with aura received lamotrigine…”
Get full text

Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence by Steiner, T. J., Göbel, H., Jensen, R., Lampl, C., Paemeleire, K., Linde, M., Braschinsky, M., Mitsikostas, D., Gil-Gouveia, R., Katsarava, Z.

“…In joint initiatives, the European Headache Federation and Lifting The Burden have described a model of structured headache services (with their basis in…”
Get full text

Guidelines for controlled trials of drugs in tension-type headache: second edition by Bendtsen, L, Bigal, M E, Cerbo, R, Diener, H C, Holroyd, K, Lampl, C, Mitsikostas, D D, Steiner, T J, Tfelt-Hansen, P

“…The Clinical Trials Subcommittee of the International Headache Society published its first edition of the guidelines on controlled trials of drugs in…”
Get more information

Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept by Bräutigam, E., Lampl, C., Track, C., Nieder, C., Pichler, J., Hammer, J., Geinitz, H.

“…Purpose The aim of this retrospective study was to evaluate survival outcomes in well-performing, mainly, young patients receiving a sequence of all available…”
Get full text

A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache by Lampl, C, Marecek, S, May, A, Bendtsen, L

“…This open study evaluates the effectiveness and safety of topiramate for the prophylaxis of chronic tension-type headache. Fifty-one patients were enrolled, of…”
Get more information

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research by Steiner, T. J., Lipton, R. B.

“…Background The burden attributable to headache disorders has multiple components: a simple measure summarising them all does not exist. The Migraine Disability…”
Get full text

Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age by Lampl, C., You, X., Limmroth, V.

“…Background:  Efficacy and safety data have not previously been compiled for intramuscular interferon beta‐1a (IM IFNβ‐1a) in patients with multiple sclerosis…”
Get full text

L-Dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia by BONELLI, S. B, RANSMAYR, G, STEFFELBAUER, M, LUKAS, T, LAMPL, C, DEIBL, M

“…The authors analyzed whether nondemented (PD) and demented Parkinson patients (PDD) and patients with dementia with Lewy bodies (DLB) respond similarly in the…”
Get full text

The Eurolight project: the impact of primary headache disorders in Europe. Description of methods by Andrée, C., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lanteri-Minet, M., Mick, G., Rastenyte, D., de la Torre, E. Ruiz, Tassorelli, C., Vriezen, P., Lampl, C.

“…The Eurolight project is the first at European Union level to assess the impact of headache disorders, and also the first of its scale performed by…”
Get full text

Amitriptyline in the prophylaxis of central poststroke pain: Preliminary results of 39 patients in a placebo-controlled, long-term study by LAMPL, Christian, YAZDI, Kambiz, ROPER, Christoph

“…We performed a double-blind, placebo-controlled study to investigate the effectiveness of amitriptyline for the prophylactic treatment of patients with acute…”
Get full text

Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society by Straube, A, Gaul, C, Förderreuther, S, Kropp, P, Marziniak, M, Evers, S, Jost, W H, Göbel, H, Lampl, C, Sándor, P S, Gantenbein, A R, Diener, H-C

“…Chronic migraine (CM) was first defined in the second edition of the International Headache Society (IHS) classification in 2004. The definition currently used…”
Get full text

Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke by Seifert-Held, T, Pekar, T, Gattringer, T, Simmet, N.E, Scharnagl, H, Bocksrucker, C, Lampl, C, Storch, M.K, Stojakovic, T, Fazekas, F

Get full text

Migraine and stroke - why do we talk about it? by Lampl, C., Marecek, S.

“…Data from observational studies suggest that migraine may be a risk factor for stroke. Furthermore, a significant association between migraine and ischemic…”
Get full text

Two different doses of Amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors by Lampl, C., Huber, G., Adl, J., Luthringshausen, G., Franz, G., Marecek, S., Weber, J., Baumhackl, U., Mueller, T.

“…Background and purpose:  The rationale for our study was to examine the prophylactic benefit of two doses of amitriptyline over a 6‐month observational period…”
Get full text

Difference in triptan effect in patients with migraine and early allodynia by Lampl, C, Huber, G, Haas, S, Rittberger, E, Diener, H C

“…The aim of this study was to determine whether in migraine patients with and without aura early treatment with various triptans leads to differences in pain…”
Get more information

Lamotrigine in the prophylactic treatment of migraine aura--a pilot study by Lampl, C, Buzath, A, Klinger, D, Neumann, K

“…The aim of this study was to evaluate the efficacy of lamotrigine, a glutamate antagonist blocking voltage-sensitive sodium channels, in the prophylaxis of…”
Get more information